Product Details
Product Sizes
| Size | List Price | Price | Cart |
|---|---|---|---|
| 500,000 Cells | $777.60 | Add to Cart |
Human Prostate Carcinoma Cells (LNCaP Clone FGC) were derived from a prostate carcinoma patient. LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old Caucasian male (blood type B+) with a confirmed diagnosis of metastatic prostate carcinoma. LNCaP cells are sensitive to androgens unlike other prostate cancer cell lines. Cells are supplied in frozen vials with more than 5x10^5 cells/vial. Universal Full Growth Medium (TM001) is recommended to culture the cells. Cells are prepared and manufactured in an ISO 9001:2015 certified environment and ISO 5 cleanroom. Product Highlights: |
Supporting Products
| Name | Catalog # | Size |
|---|---|---|
| Cell Detachment Solution | ADF001 | 50 ml |
| Universal Full Growth Medium | TM001 | 500 ml |
- Product Reviews
Leave a review for this product and you could be eligible for a $10 Starbucks gift card.
- Product Publications
Product Publications
If you've used this product in a publication, let us know. Email pshuster@neuromics.com, with the publication details and you could be eligible for an Amazon gift card.
- Related Products
Related Products
Name Catalog # Size GFP Expressing Human Prostate Carcinoma Cells (DU 145) TR03-GFP 500,000 Cells Human Prostate Carcinoma Cells (DU 145) DU001 500,000 Cells Human Prostate Carcinoma Cells (PC-3) PC001 500,000 Cells Human Prostate Carcinoma Cells (VcaP) VC001 500,000 Cells RFP Expressing Human Prostate Carcinoma Cells (DU 145) TR03-RFP 500,000 Cells
Images
LNCaP cells in culture.
LNCaP cells in culture.
LNCaP cells in culture.
LNCaP cells in culture.